
Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. (KYTX)
WebsitePrice
Market cap
Next catalystAt ASH 2026, December 12–15; session date not suppliedMiv-cel — KYSA-8 / stiff person syndrome · Data readoutCompany release ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
KYV-201
CD19
PreINDP1P2P3FilingApproved